Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (Q2)Sep 30, 2019 | (Q1)Jun 30, 2019 | (FY)Mar 31, 2019 | (Q2)Sep 30, 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 7.41%81.21M | 7.60%75.61M | -37.84%70.27M | 2.18%113.04M | 75.41%110.63M | -13.13%63.07M | -49.19%16.55M | 105.09%11.89M | -19.34%72.61M | 32.58M |
| Cost of revenue | 3.73%42.51M | -16.87%40.98M | -23.92%49.3M | 14.19%64.8M | 70.10%56.75M | -18.47%33.36M | -48.84%8.74M | 74.50%6.45M | -20.29%40.92M | 17.08M |
| Gross profit | 11.76%38.71M | 65.15%34.63M | -56.53%20.97M | -10.48%48.24M | 81.37%53.88M | -6.23%29.71M | -49.58%7.82M | 158.95%5.44M | -18.07%31.68M | 15.5M |
| Operating expense | -4.54%28.29M | -4.85%29.64M | 7.99%31.15M | -5.51%28.85M | 51.73%30.53M | 7.71%20.12M | 42.73%5.59M | -3.17%3.58M | -0.45%18.68M | 3.91M |
| Selling and administrative expenses | -4.54%28.29M | -4.85%29.64M | 7.99%31.15M | -5.51%28.85M | 51.73%30.53M | 7.71%20.12M | 42.73%5.59M | 19.02%4.45M | -0.45%18.68M | --3.91M |
| -Selling and marketing expense | -62.75%3.57M | -29.67%9.57M | 59.37%13.61M | -49.81%8.54M | 76.64%17.01M | 54.77%9.63M | 227.81%2.97M | 160.79%2.1M | -13.75%6.22M | --906K |
| -General and administrative expense | 23.22%24.73M | 14.39%20.07M | -13.62%17.54M | 50.23%20.31M | 28.87%13.52M | -15.80%10.49M | -13.04%2.62M | -19.95%2.35M | 7.85%12.46M | --3.01M |
| Total other operating income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 1,925.58%871K | ---- | ---- |
| Operating profit | 108.53%10.41M | 149.06%4.99M | -152.50%-10.18M | -16.97%19.39M | 143.55%23.35M | -26.26%9.59M | -80.75%2.23M | 216.61%1.86M | -34.68%13M | 11.59M |
| Net non-operating interest income expense | -14.36%-1.04M | -64.85%-905K | -206.70%-549K | -4.68%-179K | 61.66%-171K | -71.54%-446K | -26.00%-126K | -8.33%-117K | 16.67%-260K | -100K |
| Non-operating interest income | 9.86%836K | 11.42%761K | -8.57%683K | 161.19%747K | 615.00%286K | -82.83%40K | ---- | ---- | 33.14%233K | ---- |
| Non-operating interest expense | 11.94%1.87M | 35.23%1.67M | 43.93%1.23M | 87.31%856K | -5.97%457K | -1.42%486K | 26.00%126K | 8.33%117K | 1.86%493K | --100K |
| Total other finance cost | --6K | ---- | ---- | --70K | ---- | ---- | ---- | ---- | ---- | ---- |
| Net investment income | -471.98%-2.96M | 202.66%796K | 8.23%263K | -83.70%243K | 200.54%1.49M | -508.54%-1.48M | 108.82%363K | |||
| Gain/Loss on financial instruments designated as cash flow hedges | ||||||||||
| Gain/Loss on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income /charges | -17.04M | 0 | ||||||||
| Less:Impairment of capital assets | --3.49M | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Write off | --13.55M | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income /expenses | 75.26%340K | 3.74%194K | 3.89%187K | -38.14%180K | 51.56%291K | 69.91%192K | 206.78%181K | -26.14%113K | 59K | |
| Income before tax | -244.16%-7.32M | 149.41%5.08M | -152.35%-10.28M | -21.35%19.64M | 217.94%24.97M | -40.61%7.85M | -80.21%2.29M | 202.35%1.74M | -15.45%13.22M | 11.55M |
| Income tax | -86.34%484K | 203.77%3.54M | -82.09%1.17M | -12.89%6.51M | 166.90%7.48M | -9.12%2.8M | -78.59%453K | 1,823.81%404K | -17.28%3.08M | 2.12M |
| Net income | -607.87%-7.81M | 113.43%1.54M | -187.21%-11.45M | -24.96%13.12M | 246.25%17.49M | -50.18%5.05M | -80.57%1.83M | 177.67%1.34M | -14.87%10.14M | 9.43M |
| Net income continuous operations | -607.87%-7.81M | 113.43%1.54M | -187.21%-11.45M | -24.96%13.12M | 246.25%17.49M | -50.18%5.05M | -80.57%1.83M | 177.67%1.34M | -14.87%10.14M | --9.43M |
| Noncontrolling interests | 0.00%-1K | -1K | 0 | 93.75%-1K | 63.64%-16K | 85.48%-44K | 85.61%-19K | 70.83%-14K | -247.09%-303K | -132K |
| Net income attributable to the company | -607.48%-7.81M | 113.44%1.54M | -187.21%-11.45M | -25.03%13.12M | 243.57%17.51M | -51.20%5.1M | -80.64%1.85M | 180.73%1.35M | -10.78%10.44M | 9.56M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -607.48%-7.81M | 113.44%1.54M | -187.21%-11.45M | -25.03%13.12M | 243.57%17.51M | -51.20%5.1M | -80.64%1.85M | 180.73%1.35M | -10.78%10.44M | 9.56M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -606.52%-0.0233 | 113.45%0.0046 | -187.02%-0.0342 | -25.99%0.0393 | 242.58%0.0531 | -51.05%0.0155 | -80.69%0.0056 | 175.46%0.0041 | -16.67%0.0317 | 0.029 |
| Diluted earnings per share | -606.52%-0.0233 | 113.45%0.0046 | -187.02%-0.0342 | -25.99%0.0393 | 242.58%0.0531 | -51.05%0.0155 | -80.69%0.0056 | 175.46%0.0041 | -16.67%0.0317 | 0.029 |
| Dividend per share | 0 | 0 | -76.18%0.0065 | 33.66%0.0271 | 303.94%0.0203 | -15.84%0.005 | -15.84%0.005 | 0 | 0.006 | 0.006 |
| Currency Unit | MYR | MYR | MYR | MYR | MYR | MYR | MYR | MYR | MYR | MYR |